Table 2.
CTC Repeat Test Results of Cancer Patients Undergoing Treatment Incl. Surgery, Radio-, or FDA-Approved Chemotherapy (Group 1)
| Patient ID, age | Cancer type | Test ID | CTC test time points (A-D) | CTC count/ml | N months between CTC tests | Treatment details and comments |
|---|---|---|---|---|---|---|
| F1, 62 yrs | Colorectal | 292GL | A: Sep-15 | 0.4 | A: After surgery, radio, chemo | |
| 383GL | B: Jan-16 | 1.2 | 4 | |||
| 437GL | C: Mar-16 | 3.5 | 3 | C: Liver metastases detected | ||
| 595GL | D: Jul-16 | 1.9 | 4 | |||
| F2, 60 yrs | Colorectal | 338VD | A: Nov-15 | 0 | ||
| 405VD | B: Feb-16 | 0 | 3 | |||
| 592VD | C: Jul-16 | 21.1 | 5 | C: Lung metastases detected | ||
| F3, 41 yrs | Colorectal | 343NZ | A: Nov-15 | 2 | ||
| 609NZ | B: Jul-16 | 6.1 | 8 | B: Ongoing herbal therapy, details unknown | ||
| 782NZ | C: Dec-16 | 13.3 | 5 | |||
| F4, 33 yrs | Colorectal, sigmoid | 691GK | A: Oct-16 | 13.2 | ||
| 725GK | B: Nov-16 | 1 | 1 | B: After hyperthermia, IVC, IV-Curcumin | ||
| F5, 71 yrs | Breast | 171WS | A: May-15 | 0.6 | A: After surgery, radio | |
| 291WS | B: Sept-15 | 19.2 | 4 | B: Ongoing hormonal therapy, low Vit D level | ||
| 458WS | C: Apr-16 | 0.1 | 7 | C: After vitamin D, curcumin, relaxation | ||
| F6, 66 yrs | Breast | 296JWK | A: Sep-15 | 0.5 | A: After surgery | |
| 483JWK | B: Apr-16 | 2.5 | 7 | B: On chemo | ||
| F7, 65 yrs | Breast, bone, liver | 417SM | A: Feb-16 | 1.2 | A: Surgery 5 yrs ago | |
| 496SM | B:May-16 | 2.6 | 3 | B: Ongoing chemo | ||
| F8, 46 yrs | Breast | 255JB | A: Jul-15 | 0.1 | A: After surgery, chemo, radio a year earlier | |
| 497JB | B: May-16 | 6.6 | 10 | |||
| F9, 44 yrs | Breast | 153AB | A: May-15 | 2.6 | ||
| 390AB | B: Jan-16 | 0.7 | 8 | B: After surgery | ||
| F10, 42 yrs | Breast | 579DM | A: Jul-16 | 2.4 | ||
| 731DM | B: Nov-16 | 13 | 4 | B: After surgery, radio, chemo | ||
| F11, 63 yrs | Breast | 656DM | A: Aug-16 | 0.3 | 3 | |
| 763DM | B: Nov-16 | 3.2 | B: After radio, chemo, supplements | |||
| M12, 35 yrs | Gastric | 460MM | A: Apr-16 | 4.7 | A: Ongoing chemo | |
| 690MM | B: Oct-16 | 0.1 | 6 | B: Chemo + immunotherapy drug | ||
| F13, 57 yrs | Melanoma | 27EN | A: Nov-14 | 7.2 | A: Melanoma detected | |
| 449EN | B: Mar-16 | 1.1 | 16 | B: After surgery | ||
| M14, 51 yrs | Lung | 64SW | A: Nov-15 | 1.2 | 3 | A: After CTC screening 4 mm tumour detected, non-smoker, asbestos exposure |
| 427SW | B: Feb-16 | 0.9 | B: After surgery | |||
| F15, 48 yrs | Ovarian | 602GN | A: Jul-16 | 1.1 | 5 | |
| 775GN | B: Dec-16 | 1.1 | B: Ongoing chemo | |||
| M16, 65 yrs | Prostate | 534NM | A: May-16 | 6.2 | ||
| 757NM | B: Nov-16 | 0.8 | 6 | B: Sonotherapy, supplements |
F, female; M, male